Racial and ethnic disparities in COVID-19 infections are not explained by social risk factors
New Kaiser Permanente study suggests working and living conditions may be key contributors to disproportionate impact of COVID-19 in communities of color.
No serious health effects linked to mRNA COVID-19 vaccines
Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.
New tool for early identification of COVID-19 surges
Health systems could use data from routine clinical care to identify the onset of upcoming COVID-19 surges as many as 6 weeks before they occur, Kaiser Permanente researchers found in a study published in the journal BMJ Open.
Risk of blood clots more than 3-fold higher in hospitalized adults with COVID-19
Kaiser Permanente study found Black patients as well as patients who had obesity, liver disease, or sepsis or other signs of infection were among those more likely to be at high risk for a blood clot.
‘COVID toes’ were likely not caused by COVID-19, in most cases
Kaiser Permanente study suggests the increased incidence of chilblains — or, COVID toes — seen during pandemic was related to behavior changes, not the coronavirus.
COVID-19 vaccine trial enrolls children aged 5-11 at 3 sites in Northern California
About 75 children are scheduled to receive their first vaccination against COVID-19 as part of the Pfizer/BioNTech vaccine clinical trial through Kaiser Permanente Northern California.
Blood clot risk low in non-hospitalized COVID-19 patients
COVID-19 patients who are not hospitalized are at low risk of developing blood clots and should not routinely be prescribed blood thinners, a new Kaiser Permanente research letter suggests.
Analysis confirms racial disparities in COVID-19 infection
An analysis of Kaiser Permanente members in Northern California early in the COVID-19 pandemic found racial and ethnic disparities in the likelihood of testing positive for the coronavirus, but no significant disparities in mortality among those who were hospitalized.
Kaiser Permanente data key to nation’s COVID-19 vaccine surveillance strategy
Kaiser Permanente’s Vaccine Study Center is leading a key part of the national safety surveillance effort for the COVID-19 vaccines, tracking patient data for serious side effects.
COVID-19 antibody research to illuminate pandemic’s course in Northern California
Researchers with Kaiser Permanente are launching a study using blood tests for antibodies to the SARS-CoV-2 virus to estimate the prevalence and incidence of COVID-19 disease in Northern California and explore whether antibodies confer protection from recurrent disease.
